Ketamine: Mechanisms and Relevance to Treatment of Depression

Annual Review of Medicine · Published 2023-09-20 · DOI 10.1146/annurev-med-051322-120608

Authors being retrieved — see the publisher record. https://doi.org/10.1146/annurev-med-051322-120608

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2023

Related articles

Dimensional effect profiles in treatment-resistant depression: A naturalistic, prospective head-to-head comparison of arTMS, esketamine nasal spray, and oral brexpiprazole · Journal of Affective Disorders · 2026 · Cites or is cited by this article
NDP-MSH rescues LPS-induced neuroinflammation, synaptic deficits, and depressive-like behaviors in mice: involvement of MC1R–cAMP/PKA signaling · Frontiers in Pharmacology · 2026 · Cites or is cited by this article
Rapid clinical and EEG microstate changes 24 h after intranasal esketamine in major depressive disorder with suicidal ideation: a prospective paired study · Journal of Affective Disorders · 2026 · Cites or is cited by this article
New Oral Selective Estrogen Receptor Degraders Redefine Management of Estrogen Receptor–Positive Breast Cancer · Annual Review of Medicine · 2025 · Same journal
CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and Beyond · Annual Review of Medicine · 2024 · Same journal
Emerging Long-Term Risks of the Use of Proton Pump Inhibitors and Potassium-Competitive Acid Blockers · Annual Review of Medicine · 2024 · Same journal
Biologic Medications for Severe Asthma: Implications for Understanding Pathogenic Heterogeneity and Endotypes · Annual Review of Medicine · 2024 · Same journal
Lessons from the Use of Monoclonal Antibodies to SARS-CoV-2 Spike Protein During the COVID-19 Pandemic · Annual Review of Medicine · 2024 · Same journal
Advances in Therapy for Refractory Epilepsy · Annual Review of Medicine · 2024 · Same journal
Approach to Therapy for Chronic Pouchitis · Annual Review of Medicine · 2025 · Same journal